Executive Management

Ronnie Ka Wah HUI has served as the Chief Executive Officer of CURRENC Group Inc. since August 31, 2024 and has served as the Chief Executive Officer of Seamless Group Inc. since January 2022. Dr. Hui graduated from The University of Hong Kong with a Bachelor of Medicine and a Bachelor of Surgery. He is a member of the Royal College of Physicians of the United Kingdom, a fellow member of the Hong Kong Academy of Medicine (Paediatrics), and a fellow member of the Hong Kong College of Paediatricians. Dr. Hui has been practicing as a Specialist in Paediatrics in Hong Kong since 1987. Dr. Hui has been granted the CFA (Chartered Financial Analyst) Charterholder since 2004 and obtained a Master of Business Administration in 2007. Dr. Hui has extensive corporate executive and financial management experience in publicly listed corporations. He had served as a senior executive in Town Health International Investment Limited, Core Healthcare Investment Holdings Limited, Hanergy Thin Film Power Group Limited, and Convoy Global Holdings Limited. In 2014, Dr. Hui was recruited to join Town Health International Medical Group Limited, which is a Hong Kong-listed healthcare conglomerate, as the Chief Executive Officer of the Group from 2014 until 2020. Dr. Hui has also served as an independent director at several other Hong Kong-listed companies, including CASH Financial Services Group, e2 Capital Group, Pricerite Group, Core Communication Group, Suncorp International Group and Winbox International Holdings Group. Dr. Hui was granted the Justice of the Peace by the Hong Kong SAR Government in 2007.

Wan Lung Eng brings over 20 years of extensive experience as a finance and accounting executive, investment banker, and private equity professional. His expertise spans corporate finance, mergers and acquisitions, capital markets, principal investments, and corporate development across diverse industries within financial institutions and corporations. He most recently served as Chief Financial Officer at VitalCheck Wellness, a global healthcare services provider, overseeing finance strategy, planning, tax, treasury, accounting, and financial reporting. Before this role, he was CFO at Teclison, a biotechnology company developing cancer therapeutics, where he led its first institutional capital raise and IPO readiness strategy,including SEC filings. Wan Lung also held the role of CFO at Spectral MD, a predictive analytics company listed on the London Stock Exchange. Under his leadership, he steered the IPO process and increased the company’s valuation by 3.8x through organizational restructuring, pricing optimization, product diversification, and international expansion. Earlier, he was Senior Vice President & CFO at Immersive Artistry, where he led strategic planning, investor relations, and capital raises. His previous roles include advising telecom, media and technology companies on M&A transactions at RBC Capital Markets and managing principal investments at Macquarie Group. He also held senior roles at Deutsche Bank, Wells Fargo, and CIAS International, a private equity firm under Temasek Holdings. Wan Lung holds an MBA from Duke University’s Fuqua School of Business and a Bachelor of Accounting from Nanyang Technological University in Singapore.